Hemophilia - 95 Studies Found

Terminated : Turkish Acquired Haemophilia Registry
: Acquired Haemophilia
: 2011-07-26
: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin According to local clinical stan
Recruiting : Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
: Acquired Haemophilia
: 2012-10-16
:
  • Drug: Steroid + cyclophosphamide
  • Drug: Ste
Recruiting : Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
: Acquired Hemophilia A
: 2015-10-29
: Biological: OBIZUR Treating physician will determine treatment regimen, frequency of laboratory and clin
No longer available : Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies
: Acquired Hemophilia A
: 2013-10-21
: Biological: OBI-1 Other Name: B-Domain Deleted Recombinant Porcine Factor VIII
Completed : Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study
:
  • Acquired Haemophilia
  • Register

: 2005-09-13
Completed : Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia
:
  • Acquired Bleeding Disorder
  • Acquired Haemophilia

: 2011-01-26
: Drug: activated recombinant human factor VII Data collection of the use of activated recombinant human f
Terminated : Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
: Hemophilia A
: 2006-03-23
:
  • Drug: Rituxan Acquired Hemophi
Completed : Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A
: Hemophilia A
: 2010-08-06
: Biological: OBI-1 Intravenous infusion
Completed : Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
:
  • Congenital Bleeding Disorder
  • Congenital FVII Deficiency
  • Gl
    : 2008-06-11
    : Drug: eptacog alfa (activated) A NON INTERVENTIONAL OBSERV
Recruiting : Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa
: Haemophilia
: 2013-05-14
Next >>>